Cell-based immunotherapy against gliomas: from bench to bedside
about
Immunocompetent murine models for the study of glioblastoma immunotherapyImmune-checkpoint blockade and active immunotherapy for glioma.Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma.The importance of the tumor microenvironment in the therapeutic management of cancer.T11TS immunotherapy repairs PI3K-AKT signaling in T-cells: Clues toward enhanced T-cell survival in rat glioma model.The biology and mathematical modelling of glioma invasion: a review.Judging a tumor cell by its cover: a matter of mitochondrial contact sites.Epstein-Barr Virus in Gliomas: Cause, Association, or Artifact?
P2860
Q33574853-BEDEB962-F01F-4554-8684-1FBCD5572C64Q37420586-76E0C5DD-825D-4509-982E-3645B42E1F82Q37477267-008228F6-F988-4C81-BE36-98E42756D5D4Q38534294-52EE0DB6-5369-4089-B39E-F527BD5051CFQ38940348-43BC4958-2AE4-42B0-8D1B-51651552DB32Q47124238-DED83136-76B3-4665-9B5A-BA3729CD359CQ48114246-A85CB01B-4AFA-4E66-8F19-B82AC7E80EC0Q55032149-75DDB8BF-C21A-4534-9BBC-E4CCEA2439B4
P2860
Cell-based immunotherapy against gliomas: from bench to bedside
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cell-based immunotherapy against gliomas: from bench to bedside
@en
type
label
Cell-based immunotherapy against gliomas: from bench to bedside
@en
prefLabel
Cell-based immunotherapy against gliomas: from bench to bedside
@en
P2093
P2860
P356
P1433
P1476
Cell-based immunotherapy against gliomas: from bench to bedside
@en
P2093
Bakhos A Tannous
M Hannah Degeling
M Sarah S Bovenberg
P2860
P304
P356
10.1038/MT.2013.80
P577
2013-05-07T00:00:00Z